Source: Journal of Cardiovascular Pharmacology. Unidade: FMRP
Subjects: ACETOFENONAS, ANTIOXIDANTES (FARMACOLOGIA), AORTA TORÁCICA (EFEITOS DE DROGAS), INIBIDORES DE ENZIMAS, PERÓXIDO DE HIDROGÊNIO (METABOLISMO), ESTRESSE OXIDATIVO, VASODILATAÇÃO
ABNT
CHOI, Hyehun e TOSTES, Rita de Cassia Aleixo e WEBB, Clinton. Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and S-nitrosylation in mouse aorta. Journal of Cardiovascular Pharmacology, v. 58, n. 5, p. 522-527, 2011Tradução . . Disponível em: https://doi.org/10.1097/FJC.0b013e31822d80a5. Acesso em: 21 out. 2024.APA
Choi, H., Tostes, R. de C. A., & Webb, C. (2011). Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and S-nitrosylation in mouse aorta. Journal of Cardiovascular Pharmacology, 58( 5), 522-527. doi:10.1097/FJC.0b013e31822d80a5NLM
Choi H, Tostes R de CA, Webb C. Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and S-nitrosylation in mouse aorta [Internet]. Journal of Cardiovascular Pharmacology. 2011 ; 58( 5): 522-527.[citado 2024 out. 21 ] Available from: https://doi.org/10.1097/FJC.0b013e31822d80a5Vancouver
Choi H, Tostes R de CA, Webb C. Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and S-nitrosylation in mouse aorta [Internet]. Journal of Cardiovascular Pharmacology. 2011 ; 58( 5): 522-527.[citado 2024 out. 21 ] Available from: https://doi.org/10.1097/FJC.0b013e31822d80a5